Area of research
Pulmonary and Respiratory Medicine · Pathology and Forensic Medicine
Research interest
Research interests include Kidney Stones and Urolithiasis Treatments, Biomedical Research and Pathophysiology, Porphyrin Metabolism and Disorders, and Chemotherapy-induced organ toxicity mitigation.
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1
End Points for Clinical Trials in Primary Hyperoxaluria
Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria
LB002ILLUMINATE-A, A PHASE 3 STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC, IN CHILDREN AND ADULTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1)
Idiopathic subglottic stenosis is associated with activation of the inflammatory IL‐17A/IL‐23 axis
Molecular analysis of idiopathic subglottic stenosis for <i>Mycobacterium</i> species
Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study
Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between